MAGNUSON TERRY 4
4 · PHARMACEUTICAL PRODUCT DEVELOPMENT INC · Filed May 21, 2010
Insider Transaction Report
Form 4
MAGNUSON TERRY
Director
Transactions
- Award
Stock Options (to buy)
2010-05-20+10,140→ 10,140 totalExercise: $25.38From: 2010-05-20Exp: 2020-05-20→ Common Stock (10,140 underlying)
Holdings
- 13,844
Common Stock
- 13,577
Stock Options (to buy)
Exercise: $19.86From: 2009-05-20Exp: 2019-05-20→ Common Stock (13,577 underlying) - 6,126
Stock Options (to buy)
Exercise: $33.82From: 2007-05-16Exp: 2017-05-15→ Common Stock (6,126 underlying) - 12,000
Stock Options (to buy)
Exercise: $12.81From: 2002-05-15Exp: 2012-05-14→ Common Stock (12,000 underlying) - 16,000
Stock Options (to buy)
Exercise: $15.06From: 2004-05-19Exp: 2014-05-18→ Common Stock (16,000 underlying) - 5,458
Stock Options (to buy)
Exercise: $23.79From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,458 underlying) - 16,000
Stock Options (to buy)
Exercise: $13.58From: 2003-05-14Exp: 2013-05-13→ Common Stock (16,000 underlying) - 6,265
Stock Options (to buy)
Exercise: $42.77From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,265 underlying) - 8,000
Stock Options (to buy)
Exercise: $15.82From: 2001-05-15Exp: 2011-05-14→ Common Stock (8,000 underlying) - 3,973
Stock Options (to buy)
Exercise: $35.38From: 2006-05-17Exp: 2016-05-16→ Common Stock (3,973 underlying)